Literature DB >> 19564339

Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection.

Constantinos Petrovas1, Benjamin Chaon, David R Ambrozak, David A Price, J Joseph Melenhorst, Brenna J Hill, Christof Geldmacher, Joseph P Casazza, Pratip K Chattopadhyay, Mario Roederer, Daniel C Douek, Yvonne M Mueller, Jeffrey M Jacobson, Viraj Kulkarni, Barbara K Felber, George N Pavlakis, Peter D Katsikis, Richard A Koup.   

Abstract

Recent studies have revealed the critical role of programmed death-1 (PD-1) in exhaustion of HIV- and SIV-specific CD8(+) T cells. In this study, we show that high expression of PD-1 correlates with increased ex vivo spontaneous and CD95/Fas-induced apoptosis, particularly in the "effector-memory" CD8(+) T cell population from HIV(+) donors. High expression of PD-1 was linked to a proapoptotic phenotype characterized by low expression of Bcl-2 and IL7-R alpha, high expression of CD95/Fas and high mitochondrial mass. Expression of PD-1 and CD57 was differentially associated with the maturation status of CD8(+) T cells in HIV infection. CD57 was linked to higher apoptosis resistance, with cells expressing a PD-1(L)CD57(H) phenotype exhibiting lower levels of cell death. The majority of HIV-specific CD8(+) T cells were found to express a PD-1(H)CD57(L) or PD-1(H)CD57(H) phenotype. No correlation was found between PD-1 expression and ex vivo polyfunctionality of either HIV- or CMV-specific CD8(+) T cells. Contrary to CD57, high expression of PD-1 was characterized by translocation of PD-1 into the area of CD95/Fas-capping, an early necessary step of CD95/Fas-induced apoptosis. Thus, our data further support the role of PD-1 as a preapoptotic factor for CD8(+) T cells in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564339      PMCID: PMC2923541          DOI: 10.4049/jimmunol.0900182

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

Review 1.  Regulation of T lymphocyte metabolism.

Authors:  Kenneth A Frauwirth; Craig B Thompson
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

Review 2.  Homeostasis of memory T cells.

Authors:  Charles D Surh; Onur Boyman; Jared F Purton; Jonathan Sprent
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

3.  Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release, and activation of caspases in human eosinophils.

Authors:  G Dewson; G M Cohen; A J Wardlaw
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

4.  Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239.

Authors:  Meritxell Genescà; Tracy Rourke; Jun Li; Kristen Bost; Barinderpaul Chohan; Michael B McChesney; Christopher J Miller
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

5.  Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.

Authors:  Zheng Zhang; Ji-Yuan Zhang; E John Wherry; Bo Jin; Bin Xu; Zheng-Sheng Zou; Shu-Ye Zhang; Bao-Sen Li; Hui-Feng Wang; Hao Wu; George K K Lau; Yang-Xin Fu; Fu-Sheng Wang
Journal:  Gastroenterology       Date:  2008-03-22       Impact factor: 22.682

6.  SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation.

Authors:  Jens M Chemnitz; Richard V Parry; Kim E Nichols; Carl H June; James L Riley
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

7.  Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain.

Authors:  X N Xu; B Laffert; G R Screaton; M Kraft; D Wolf; W Kolanus; J Mongkolsapay; A J McMichael; A S Baur
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

8.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

9.  Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity.

Authors:  Peter D Hughes; Gabrielle T Belz; Karen A Fortner; Ralph C Budd; Andreas Strasser; Philippe Bouillet
Journal:  Immunity       Date:  2008-02       Impact factor: 43.474

10.  Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses.

Authors:  Melissa L Precopio; Michael R Betts; Janie Parrino; David A Price; Emma Gostick; David R Ambrozak; Tedi E Asher; Daniel C Douek; Alexandre Harari; Giuseppe Pantaleo; Robert Bailer; Barney S Graham; Mario Roederer; Richard A Koup
Journal:  J Exp Med       Date:  2007-05-29       Impact factor: 14.307

View more
  61 in total

1.  Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.

Authors:  Joseph A Conrad; Ramesh K Ramalingam; Coley B Duncan; Rita M Smith; Jie Wei; Louise Barnett; Brenna C Simons; Shelly L Lorey; Spyros A Kalams
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

2.  Age-related deregulation of naive T cell homeostasis in elderly humans.

Authors:  Sara Ferrando-Martínez; Ezequiel Ruiz-Mateos; Ana Hernández; Encarnación Gutiérrez; Maria del Mar Rodríguez-Méndez; Antonio Ordoñez; Manuel Leal
Journal:  Age (Dordr)       Date:  2010-08-11

3.  Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle.

Authors:  Tomohiro Okagawa; Satoru Konnai; James R Deringer; Massaro W Ueti; Glen A Scoles; Shiro Murata; Kazuhiko Ohashi; Wendy C Brown
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

4.  Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.

Authors:  Malika Hale; Taylor Mesojednik; Guillermo S Romano Ibarra; Jaya Sahni; Alison Bernard; Karen Sommer; Andrew M Scharenberg; David J Rawlings; Thor A Wagner
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

Review 5.  New approaches to design HIV-1 T-cell vaccines.

Authors:  Hélène Perrin; Glenda Canderan; Rafick-Pierre Sékaly; Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

6.  Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.

Authors:  Kehmia Titanji; Vijayakumar Velu; Lakshmi Chennareddi; Matam Vijay-Kumar; Andrew T Gewirtz; Gordon J Freeman; Rama R Amara
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

Review 7.  Biomarkers of immune dysfunction in HIV.

Authors:  Daniel E Nixon; Alan L Landay
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

Review 8.  Bispecific antibodies: Potential immunotherapies for HIV treatment.

Authors:  Giulia Fabozzi; Amarendra Pegu; Richard A Koup; Constantinos Petrovas
Journal:  Methods       Date:  2018-10-22       Impact factor: 3.608

Review 9.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage.

Authors:  Thomas C Greenough; Shalyn C Campellone; Robin Brody; Surbhi Jain; Victor Sanchez-Merino; Mohan Somasundaran; Katherine Luzuriaga
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.